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Introduction
Hyperbilirubinemia, also known as 
jaundice, is a clinical condition in babies 
characterized by yellowish skin and sclera 
due to increased serum bilirubin levels.1 The 
majority of jaundice is generally classified as 
physiological, however, the rest still have a 
potential to become pathological with a higher 
risk of various complications. Therefore, the 
incidence of jaundice needs attention.2 The 
prevalence of babies with hyperbilirubinemia 
in the United States3 is 65%, in Nigeria4 33%, 
and in Malaysia5 75%. In Indonesia, the 
incidence of jaundice in term babies, especially 
in West Java Province, is ranging from 10.4% 
to 85%.3,6 
Causes of hyperbillirubinemia are 
considered to be predisposing factor, and 
common causes include maternal, perinatal 
and neonatal factors.7 These causes are also 
influenced by several risk factors, such as 
preterm babies (<37 weeks), babies with low 
birth weight (LBW), and the mode of delivery.8 
Jaundice is a problem in neonates that is often 
faced by health professionals, which occurs 
in about 60% of term neonates and is even 
higher in preterm neonates.6 Therefore, the 
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Abstract
Background: Neonates are prone to hyperbilirubinemia or jaundice due to the immaturity of various 
organ systems and complications at birth.  Immature organ systems occur primarily in preterm babies 
and babies with low birth weight (LBW).  The incidence of hyperbilirubinemia is about 60% among 
term neonates and is higher in preterm neonates. This study aimed to determine the characteristics of 
neonates with hyperbilirubinemia.
Methods: This study used a cross sectional research design. Samples were obtained from medical 
records of neonates with hyperbilirubinemia throughout 2019 at Annisa Medical Center Hospital, 
Bandung Regency. Data on neonates that met the inclusion criteria were selected, including gender, 
gestational age, birth weight, mode of delivery, bilirubin levels (before and after phototherapy), and 
duration of treatment. Data analysis was performed using univariate statistical calculations.
Results: From 786 data obtained, the prevalence rate of hyperbilirubinemia was 21.2%. Male 
neonates with hyperbilirubinemia were predominantly prevalent (n=103; 61.7%); whereas preterm 
neonates accounted for 51.5% (n=86), normal weight (85.6%), and born through vaginal delivery 
(n=116; 69.5%). After treatment, total bilirubin levels decreased, with the percentage of the >10 
mg/dl group decreasing from 97.0% to 10.2%. The average duration of treatment for neonates with 
hyperbilirubinemia was 4.4 days, however, the neonates who were treated less than the average were 
71.3%. 
Conclusions: Preterm male is predominantly prevalent among neonates with hyperbilirubinemia, 
although they have conformed birth weight and vaginal delivery mode. The duration of treatment for 
neonates with hyperbilirubinemia mostly does not exceed 4 days, as long as the treatment reduces the 
total bilirubin level. Good therapeutic management in the first week of hyperbilirubinemia neonates 
is required.
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examination of jaundice in neonates should be 
carried out at the time of the neonatal visit or 
when examining the babies at the clinic.6 This 
problem is related to the Neonatal Mortality 
Rate (NMR) in Indonesia of 15 deaths per 
1000 births in 2017, which is relatively high,9 
compared to the World Health Organization 
(WHO) sustainable developments target of 12 
deaths per 1000 births.10
Considering that there are still many 
neonates who experience hyperbilirubinemia, 
including in West Java and Bandung Regency, 
this study aimed to explore the characteristics 
of neonates suffering from hyperbilirubinemia 
at Annisa Medical Center (AMC) Hospital 
Bandung Regency.
Methods
The research was a descriptive study, involving 
data on neonates with hyperbilirubinemia 
recorded at the Annisa Medical Center (AMC) 
Hospital Bandung Regency in 2019. Data on 
gender, gestational age, birth weight, mode of 
delivery, total bilirubin levels, and duration of 
treatment were noted. This research obtained 
permission from the Ethics Committee of 
Universitas Padjadjaran with the number 
1066/UN6.KEP/EC/2020.
The data was further explored using 
the Microsoft Office Excel program, and 
the univariate method was conducted to 
determine the characteristics of neonates with 
hyperbilirubinemia according to the variables 
reviewed. The data were then presented in 
frequency.
Results
In total, 786 neonates were recorded, of 
which 167 had hyperbilirubinemia, thus 
the prevalence rate of neonates with 
hyperbilirubinemia at AMC Hospital Bandung 
Regency was 21.2%. Male neonates were 
the most prevalent neonates (61.7%) with 
hyperbilirubinemia. Furthermore, 51.5% of 
the neonates were preterm although most had 
normal birth weight based on gestastional age 
(85.6%). Most of the neonates were born by 
normal vaginal delivery. 
Based on total bilirubin levels, most of the 
neonates had lower total bilirubin level after 
treatment and most of them were hospitalized 
for less or equal to 4 days as shown in Table.
Table Characteristics of Neonates with Hyperbilirubinemia (n=167) Registered at AMC 
             Hospital Bandung Regency in 2019
Characteristics n %
Gender
     Male






     Full term






     Normal
     Low








     Cesarean section





Total Bilirubin Level (mg/dl)
     Before Treatment
          <10
          >10
     After Treatment
          <10
          >10
     Treatment Duration (days)
          <4
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When all neonates were included, the 
percentage of neonates with normal birth 
weight who experienced hyperbilirubinemia 
was 20.6%. Low birth weight neonates who 
had hyperbilirubinemia were 24.7%, whereas 
very low birth weight neonates who had 
hyperbilirubinemia were 50.0%. Similarly 
for the mode of delivery, the percentage 
of neonates born by cesarean section who 
experienced hyperbilirubinemia was 22.9% 
and through vaginal delivery was 20.6% (data 
not shown).
Discussions
The prevalence rate of neonates with 
hyperbilirubinaemia in this study was 21.2%, 
and compared to the Cileunyi area and its 
surrounding in East Bandung, this number 
is still relatively high.11 Male neonates were 
predominantly prevalent (61.7%), similar 
to another study conducted previously at a 
tertiary hosiptal in Bandung.11 However, the 
effect of gender on the increase in bilirubin 
levels is still unclear. Factors that are thought 
to influence the metabolism of bilirubin in 
male babies are the Y chromosome which 
causes increased metabolism and deficiency of 
enzyme system maturation in the formation, 
metabolism, and elimination of serum 
bilirubin.6
The percentage of preterm neonates with 
hyperbilirubinemia was 51.5%. Preterm 
neonates are more prone to hyperbilirubinemia 
than term neonates.12 This might be related to 
organ immaturity in premature babies, which 
causes physiological functions to not work 
properly. The low activity of the enzyme uridine 
diphosphate glucuronyl transferase (UDPGT) 
causes a low ability to conjugate bilirubin in 
neonates. Moreover, the short lifespan of red 
blood cells in neonates leads to an increase 
in the hemolysis process, which results in an 
increase in unconjugated bilirubin.12
Furthermore, there is a higher risk for 
immaturity of the hepatic organs in neonates 
with low birth weight leading to low excretion 
of bilirubin, leading to  increased bilirubin levels 
in the blood.12 Interestingly, our study showed 
that the majority of neonates (85.6%) with 
normal birth weight had hyperbilirubinemia, 
similar to other studies which showed that 
the percentage of neonates with normal 
birth weight tended to be high.13–15 These 
results contradict the previously mentioned 
hypothesis.12 The number of patients might 
limit the statistical analysis, therefore, further 
studies with a larger number of neonates 
should be performed. 
Moreover, most of neonates with 
hyperbilirubinemia were born through 
normal vaginal delivery, similar to the study 
in Yogyakarta.16 However, in another place in 
Bogor, West Java, half of the neonates with 
hyperbilirubinemia were born by assisted 
abnormal birth mode delivery and cesarean 
section.17 The study explains that it may be 
due to the possibility of various complications 
during delivery through the procedure.7
In this study, before treatment, 97% of 
neonates with hyperbilirubinemia had a total 
bilirubin level of >10 mg/dl, which decreased 
after treatment. However, 10.2% still has a high 
level. After 24 hours of treatment, preterm 
neonates decreased by 2.25 mg/dl, whereas 
term neonates by 2.6 mg/dl.3 Interestingly, 
another study showed that the average total 
bilirubin level after phototherapy treatment 
decreased by 4.64 mg/dL, whereas if additional 
massage therapy or field massage was applied, 
the average total bilirubin level decreased 
further by 7.17 mg/dl.18 These results 
indicate that treatment given to neonates with 
hyperbilirubinemia is effective in reducing 
bilirubin levels; the closer phototherapy is to 
the body, the more effective it is.19 In addition, 
another study reported that there was no 
significant difference in phototherapy position 
in either the supine position or position 
change because the number of areas treated 
with phototherapy was the same despite the 
change in position.20 In this study, neonates 
with hyperbilirubinemia have been treated 
an average of 4.4 days (range 2–21 days). 
However, most of the neonates (71.3%) had 
been treated for less than 4 days, similar to 
another study in Sanglah Hospital.5
In conclusion, neonates with 
hyperbilirubinemia are predominantly male 
and preterm. However, normal birth weight, 
and vaginal delivery have the potential to 
develop hyperbilirubinaemia. Appropriate 
treatment may reduce total bilirubin levels to 
normal levels. 
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